| 11980633 |
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors |
Diane Boucher, Shawn Hillier, Wanjung Tsai, Brian Hare, David A. Newsome +1 more |
2024-05-14 |
$617,872,000 |
| 11110108 |
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors |
Diane Boucher, Shawn Hillier, Wanjung Tsai, Brian Hare, David A. Newsome +1 more |
2021-09-07 |
$188,614,000 |
| 8663629 |
Kallikrein-binding “kunitz domain” proteins and analogues thereof |
Robert Charles Ladner |
2014-03-04 |
$9,337,000 |
| 8431359 |
Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domains |
Robert Charles Ladner |
2013-04-30 |
$3,992,000 |
| 8283321 |
Kallikrein-binding “Kunitz domain” proteins and analogues thereof |
Robert Charles Ladner |
2012-10-09 |
$2,664,000 |
| 8002891 |
Crystallization of C-Jun N-Terminal Kinase 3 (JNK3) |
Xiaoling Xie, Yong Gu, Michael Su, Paul R. Caron, Edward J. Fox +1 more |
2011-08-23 |
$26,545,000 |
| 7919462 |
Inhibitors of human plasmin derived from the Kunitz domains |
Robert Charles Ladner |
2011-04-05 |
$1,516,000 |
| 7893007 |
Directed evolution of novel binding proteins |
Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
2011-02-22 |
$1,600,000 |
| 7628983 |
Kallikrein-binding “Kunitz domain” proteins and analogues thereof |
Robert Charles Ladner |
2009-12-08 |
$5,531,000 |
| 7413537 |
Directed evolution of disulfide-bonded micro-proteins |
Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
2008-08-19 |
$3,973,000 |
| 7383135 |
Methods of designing inhibitors for JNK kinases |
Xiaoling Xie, Yong Gu, Michael Su, Paul R. Caron, Edward J. Fox +1 more |
2008-06-03 |
$29,737,000 |
| 7256094 |
Method for changing threshold voltage of device in resist asher |
Chungdar Daniel Wang |
2007-08-14 |
$3,878,000 |
| 7208293 |
Directed evolution of novel binding proteins |
Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
2007-04-24 |
$4,346,000 |
| 7118879 |
Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material |
Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
2006-10-10 |
$989,000 |
| 7078383 |
ITI-D1 Kunitz domain mutants as HNE inhibitors |
Arthur C. Ley, Sonia Guterman, Rachel Kent, Bruce Lindsay Roberts, Robert Charles Ladner |
2006-07-18 |
$1,588,000 |
| 6979538 |
Directed evolution of novel binding proteins |
Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
2005-12-27 |
$2,555,000 |
| 6953674 |
Inhibitors of human plasmin derived from the kunitz domains |
Robert Charles Ladner |
2005-10-11 |
$2,555,000 |
| 6423498 |
Variegated Kunitz domain peptide library and uses thereof |
Robert Charles Ladner |
2002-07-23 |
$1,000,000 |
| 6333402 |
"Kallikrein-binding ""Kunitz domain"" proteins and analogues thereof" |
Robert Charles Ladner |
2001-12-25 |
|
| 6103499 |
Inhibitors of human plasmin derived from the Kunitz domains |
Robert Charles Ladner |
2000-08-15 |
|
| 6071723 |
Inhibitors of human plasmin derived from the Kunitz domains |
Robert Charles Ladner |
2000-06-06 |
|
| 6057287 |
"Kallikrein-binding ""Kunitz domain"" proteins and analogues thereof" |
Robert Charles Ladner |
2000-05-02 |
|
| 6010880 |
Inhibitors of human plasmin derived from the kunitz domains |
Robert Charles Ladner |
2000-01-04 |
|
| 5837500 |
Directed evolution of novel binding proteins |
Robert Charles Ladner, Sonia Kosow Gutterman, Bruce Lindsay Roberts, Arthur C. Ley, Rachel Kent |
1998-11-17 |
|
| 5663143 |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
Arthur C. Ley, Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, Rachel Kent |
1997-09-02 |
|